Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jose Castillo-Mancilla

Concepts (274)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-HIV Agents
52
2026
914
10.510
Why?
HIV Infections
77
2026
3215
8.500
Why?
Adenine
28
2024
339
5.410
Why?
Organophosphates
24
2025
179
5.160
Why?
Tenofovir
26
2024
300
3.990
Why?
Emtricitabine
22
2024
209
3.840
Why?
Medication Adherence
28
2024
535
3.830
Why?
Dried Blood Spot Testing
13
2024
129
3.510
Why?
Viral Load
18
2026
526
3.200
Why?
Drug Monitoring
9
2024
399
2.810
Why?
HIV-1
12
2026
913
2.070
Why?
Pre-Exposure Prophylaxis
13
2022
272
1.900
Why?
Viremia
8
2024
158
1.890
Why?
Anti-Retroviral Agents
8
2023
250
1.780
Why?
Sustained Virologic Response
4
2025
48
1.480
Why?
Blood Chemical Analysis
7
2019
109
1.020
Why?
Drug Resistance, Viral
4
2026
127
1.000
Why?
Organophosphonates
3
2015
95
0.870
Why?
HIV
6
2022
249
0.860
Why?
Adult
54
2026
41087
0.860
Why?
Deoxycytidine
3
2015
219
0.820
Why?
Diabetes Mellitus
2
2024
1101
0.800
Why?
Desiccation
2
2014
26
0.790
Why?
Humans
92
2026
146342
0.730
Why?
Awards and Prizes
1
2023
72
0.720
Why?
Prospective Studies
18
2023
8123
0.710
Why?
Specimen Handling
2
2014
178
0.710
Why?
South Africa
9
2023
262
0.670
Why?
Inflammation
6
2021
2919
0.670
Why?
Antiretroviral Therapy, Highly Active
2
2020
278
0.660
Why?
Female
57
2026
79499
0.660
Why?
Antiviral Agents
4
2019
779
0.650
Why?
Male
53
2026
73396
0.630
Why?
Middle Aged
32
2026
36619
0.590
Why?
Biomarkers
10
2022
4340
0.570
Why?
HIV Integrase Inhibitors
3
2026
80
0.560
Why?
Biomedical Research
2
2023
729
0.540
Why?
Atazanavir Sulfate
2
2016
41
0.480
Why?
CD4 Lymphocyte Count
4
2026
280
0.450
Why?
Pharmacogenetics
2
2016
176
0.440
Why?
Lymphocyte Activation
2
2018
1137
0.430
Why?
Pyridones
4
2025
210
0.420
Why?
Mental Health Services
1
2019
450
0.420
Why?
Polyphosphates
5
2022
46
0.400
Why?
Interleukin-6
5
2021
784
0.390
Why?
Chromatography, Liquid
6
2019
453
0.390
Why?
Tandem Mass Spectrometry
7
2022
576
0.390
Why?
Sexual and Gender Minorities
4
2022
269
0.380
Why?
HIV Seropositivity
2
2023
118
0.370
Why?
Immunologic Factors
1
2015
244
0.370
Why?
Transgender Persons
1
2016
213
0.370
Why?
Lipopolysaccharide Receptors
4
2021
88
0.370
Why?
Sofosbuvir
4
2022
63
0.360
Why?
Self Report
4
2023
870
0.350
Why?
Emigrants and Immigrants
2
2012
160
0.350
Why?
Fibrin Fibrinogen Degradation Products
4
2019
92
0.340
Why?
Unsafe Sex
1
2012
62
0.340
Why?
Minority Groups
1
2014
286
0.340
Why?
Hair
4
2020
81
0.330
Why?
Cupriavidus
1
2010
3
0.320
Why?
Mental Disorders
1
2019
1148
0.310
Why?
Alanine
4
2024
171
0.310
Why?
Aging
2
2021
1996
0.300
Why?
Acquired Immunodeficiency Syndrome
3
2019
238
0.300
Why?
Gram-Negative Bacterial Infections
1
2010
50
0.300
Why?
Communicable Disease Control
1
2010
88
0.300
Why?
Phosphorous Acids
2
2019
15
0.300
Why?
Clinical Trials as Topic
2
2015
1064
0.300
Why?
Prosthesis-Related Infections
1
2010
100
0.290
Why?
Leukocytes, Mononuclear
6
2021
585
0.290
Why?
Hepatitis C
3
2022
251
0.280
Why?
Homosexuality, Male
4
2022
231
0.280
Why?
Health Services Accessibility
2
2015
1107
0.280
Why?
Young Adult
16
2025
14330
0.260
Why?
Frailty
2
2022
208
0.260
Why?
RNA, Viral
3
2026
693
0.250
Why?
Peripartum Period
2
2024
19
0.250
Why?
Uganda
4
2021
91
0.250
Why?
Deoxyadenine Nucleotides
2
2016
16
0.240
Why?
Deoxycytosine Nucleotides
2
2016
13
0.240
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2022
449
0.240
Why?
Defibrillators, Implantable
1
2010
393
0.230
Why?
Comorbidity
3
2020
1665
0.230
Why?
Benchmarking
2
2024
193
0.230
Why?
Diketopiperazines
2
2022
24
0.230
Why?
Cryoglobulinemia
1
2005
5
0.220
Why?
Blood Transfusion
1
2008
394
0.220
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2005
8
0.220
Why?
Fluorenes
3
2020
46
0.220
Why?
Plasma
2
2020
222
0.220
Why?
Piperazines
2
2025
368
0.220
Why?
Lymphoproliferative Disorders
1
2005
59
0.210
Why?
Case-Control Studies
4
2022
3647
0.210
Why?
Half-Life
2
2016
157
0.210
Why?
Drug Interactions
3
2020
405
0.200
Why?
Benzimidazoles
3
2020
191
0.200
Why?
Natriuretic Peptide, Brain
1
2004
110
0.200
Why?
HIV Protease Inhibitors
2
2016
69
0.200
Why?
Cross Infection
2
2013
258
0.200
Why?
Predictive Value of Tests
2
2019
2113
0.200
Why?
Medical Waste
1
2003
2
0.190
Why?
Medical Waste Disposal
1
2003
4
0.190
Why?
Waste Management
1
2003
11
0.190
Why?
Financing, Organized
1
2023
36
0.190
Why?
Disposable Equipment
1
2003
25
0.190
Why?
Telemedicine
2
2022
966
0.190
Why?
Body Fluids
1
2003
70
0.180
Why?
Syringes
1
2003
53
0.180
Why?
Tablets
1
2022
41
0.180
Why?
National Institutes of Health (U.S.)
1
2023
147
0.180
Why?
Sexual Behavior
2
2019
490
0.180
Why?
Registries
2
2013
2400
0.180
Why?
Shock, Septic
1
2004
230
0.180
Why?
Adolescent
11
2023
22557
0.180
Why?
Demography
1
2022
274
0.180
Why?
Faculty
1
2023
152
0.180
Why?
Cell Phone
1
2022
83
0.170
Why?
Africa
1
2021
119
0.170
Why?
Protease Inhibitors
2
2020
103
0.170
Why?
Ventricular Dysfunction, Left
1
2004
391
0.170
Why?
Mentors
1
2023
217
0.160
Why?
Meningitis, Cryptococcal
1
2021
34
0.160
Why?
Longitudinal Studies
5
2023
3017
0.160
Why?
Treatment Outcome
4
2026
11821
0.150
Why?
Mobile Applications
1
2022
196
0.150
Why?
Postpartum Period
4
2024
377
0.150
Why?
Monitoring, Ambulatory
1
2020
88
0.150
Why?
Cohort Studies
4
2024
6077
0.150
Why?
Intercellular Adhesion Molecule-1
1
2019
132
0.140
Why?
Intensive Care Units
1
2005
925
0.140
Why?
Lung Diseases, Interstitial
1
2005
677
0.140
Why?
Disease Transmission, Infectious
2
2018
69
0.140
Why?
Erythrocytes
2
2016
750
0.140
Why?
Simeprevir
1
2018
5
0.130
Why?
Rectum
2
2016
180
0.130
Why?
Directly Observed Therapy
1
2017
16
0.130
Why?
Heterocyclic Compounds, 3-Ring
1
2018
44
0.130
Why?
Incidence
1
2024
2936
0.130
Why?
United States
5
2023
16136
0.130
Why?
Drug Therapy, Combination
2
2018
1036
0.120
Why?
Angiotensin Receptor Antagonists
1
2017
115
0.120
Why?
Clinical Studies as Topic
1
2016
12
0.120
Why?
Deoxyguanine Nucleotides
1
2016
12
0.120
Why?
Thymine Nucleotides
1
2016
19
0.120
Why?
Mental Health
2
2022
779
0.120
Why?
Genitalia
1
2016
32
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2017
228
0.120
Why?
Directive Counseling
1
2016
48
0.120
Why?
Qualitative Research
1
2024
1734
0.120
Why?
Radio Frequency Identification Device
1
2015
2
0.120
Why?
Peru
1
2016
61
0.120
Why?
Aged
6
2020
26432
0.110
Why?
Biological Assay
1
2016
133
0.110
Why?
Program Evaluation
1
2019
952
0.110
Why?
Drug Administration Schedule
1
2016
790
0.110
Why?
Biosensing Techniques
1
2015
143
0.100
Why?
Polymorphism, Genetic
1
2016
612
0.100
Why?
Health Status Disparities
1
2016
322
0.090
Why?
Delivery of Health Care, Integrated
1
2016
305
0.090
Why?
Kenya
2
2024
129
0.090
Why?
Enterobacteriaceae Infections
1
2013
43
0.090
Why?
Cross-Over Studies
3
2020
615
0.090
Why?
Infection Control
2
2005
174
0.090
Why?
Quality of Life
2
2022
3200
0.090
Why?
Curriculum
1
2019
1079
0.090
Why?
CD8-Positive T-Lymphocytes
1
2018
931
0.090
Why?
Ritonavir
1
2012
76
0.090
Why?
Cytochrome P-450 CYP3A
1
2012
93
0.080
Why?
Double-Blind Method
2
2026
2070
0.080
Why?
Bacteremia
1
2013
218
0.080
Why?
Cardiovascular Diseases
1
2022
2219
0.080
Why?
Oligopeptides
1
2012
264
0.080
Why?
Time Factors
5
2019
7109
0.080
Why?
Residence Characteristics
1
2013
385
0.080
Why?
Aged, 80 and over
2
2020
8391
0.080
Why?
Pregnancy
4
2024
7230
0.080
Why?
Diphosphates
2
2021
20
0.070
Why?
Cognition
1
2017
1292
0.070
Why?
Microbial Sensitivity Tests
1
2010
367
0.070
Why?
Blood Banks
1
2008
50
0.070
Why?
Logistic Models
1
2014
2126
0.070
Why?
Hepacivirus
2
2022
237
0.070
Why?
Transfusion Reaction
1
2008
61
0.070
Why?
Internship and Residency
1
2019
1281
0.070
Why?
Mexico
1
2008
233
0.070
Why?
Feasibility Studies
2
2023
1135
0.070
Why?
Surveys and Questionnaires
3
2015
6073
0.070
Why?
Pyridines
1
2012
610
0.060
Why?
Cross-Sectional Studies
1
2019
5899
0.060
Why?
Polymerase Chain Reaction
1
2010
1031
0.060
Why?
Pilot Projects
2
2023
1888
0.060
Why?
Proof of Concept Study
1
2026
90
0.060
Why?
Itraconazole
1
2006
8
0.060
Why?
Blastomycosis
1
2006
11
0.060
Why?
Molecular Sequence Data
1
2010
2838
0.060
Why?
Disease Outbreaks
1
2008
422
0.060
Why?
Age Factors
3
2019
3347
0.050
Why?
Antifungal Agents
1
2006
153
0.050
Why?
Cough
1
2006
123
0.050
Why?
HIV Integrase
1
2025
74
0.050
Why?
Hematocrit
2
2016
108
0.050
Why?
Face
1
2006
177
0.050
Why?
Polymorphism, Single Nucleotide
1
2012
2240
0.050
Why?
Retrospective Studies
3
2022
17438
0.050
Why?
Proviruses
1
2023
16
0.050
Why?
Risk Factors
3
2013
10921
0.050
Why?
Multicenter Studies as Topic
1
2005
417
0.050
Why?
Sex Factors
2
2019
2107
0.050
Why?
Eligibility Determination
1
2022
73
0.050
Why?
Telephone
1
2023
175
0.040
Why?
Rilpivirine
1
2022
10
0.040
Why?
Temperature
2
2016
635
0.040
Why?
Colorado
1
2012
4595
0.040
Why?
Interviews as Topic
1
2024
930
0.040
Why?
Social Support
1
2024
646
0.040
Why?
Point-of-Care Systems
1
2022
185
0.040
Why?
Pregnancy Complications, Infectious
1
2024
438
0.040
Why?
Anti-Bacterial Agents
1
2010
1942
0.040
Why?
Drug Combinations
1
2020
400
0.040
Why?
Uridine Monophosphate
1
2018
16
0.030
Why?
Chemoprevention
1
2018
91
0.030
Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
Why?
Metabolic Clearance Rate
1
2018
115
0.030
Why?
Ribavirin
1
2018
81
0.030
Why?
Hospitals
1
2003
738
0.030
Why?
Oxazines
1
2018
36
0.030
Why?
Healthy Volunteers
1
2018
218
0.030
Why?
Neurocognitive Disorders
1
2017
34
0.030
Why?
ROC Curve
1
2019
617
0.030
Why?
Hepatitis C, Chronic
1
2019
150
0.030
Why?
Area Under Curve
1
2018
335
0.030
Why?
CD4-Positive T-Lymphocytes
1
2023
1150
0.030
Why?
Neoplasms
1
2013
2954
0.030
Why?
Enzymes
1
2017
60
0.030
Why?
Coinfection
1
2018
143
0.030
Why?
Reproducibility of Results
2
2016
3416
0.030
Why?
Survival Analysis
1
2019
1378
0.030
Why?
Creatinine
1
2018
511
0.030
Why?
Methanol
1
2016
43
0.030
Why?
Biological Transport
1
2017
424
0.030
Why?
Spermatozoa
1
2016
103
0.030
Why?
Solutions
1
2016
160
0.030
Why?
Gelatin
1
2015
56
0.030
Why?
Down-Regulation
1
2017
614
0.030
Why?
Linear Models
1
2016
857
0.030
Why?
Patient Compliance
1
2017
589
0.020
Why?
Quality Control
1
2013
163
0.020
Why?
Calibration
1
2013
154
0.020
Why?
Drug Stability
1
2013
172
0.020
Why?
Klebsiella Infections
1
2013
26
0.020
Why?
Health Surveys
1
2015
511
0.020
Why?
Enterobacteriaceae
1
2013
44
0.020
Why?
Dose-Response Relationship, Drug
1
2017
2022
0.020
Why?
Lung
1
2006
4122
0.020
Why?
Water
1
2016
451
0.020
Why?
Computer Simulation
1
2016
1014
0.020
Why?
Refugees
1
2013
84
0.020
Why?
Kidney Failure, Chronic
1
2017
589
0.020
Why?
Hospitalization
1
2022
2475
0.020
Why?
Prognosis
1
2019
4351
0.020
Why?
Haplotypes
1
2012
506
0.020
Why?
Epithelial Cells
1
2016
1119
0.020
Why?
Models, Biological
1
2016
1761
0.020
Why?
Cost-Benefit Analysis
1
2012
640
0.020
Why?
Genotype
1
2012
1879
0.020
Why?
Lymphomatoid Granulomatosis
1
2006
5
0.010
Why?
Histoplasmosis
1
2006
15
0.010
Why?
Sporotrichosis
1
2006
6
0.010
Why?
Substance-Related Disorders
1
2013
1100
0.010
Why?
Sarcoidosis
1
2006
164
0.010
Why?
Radiography
1
2006
861
0.010
Why?
Biopsy
1
2006
1075
0.010
Why?
Diagnosis, Differential
1
2006
1503
0.010
Why?
Practice Guidelines as Topic
1
2006
1591
0.010
Why?
Castillo-Mancilla's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)